We came across a bullish thesis on Cellebrite DI Ltd. on X.com by KairosPraxis. In this article, we will summarize the bulls’ thesis on CLBT. Cellebrite DI Ltd.'s share was trading at $16.86 as of November 28th. CLBT’s trailing P/E was 44.37 according to Yahoo Finance.
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. CLBT reported Q3 earnings that impressed the market, sending shares up 20%, driven by strong execution and resilient operations. The company demonstrated solid...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.